Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men
Clinical trial NCT02943239 · COMPLETED
Trial details
- NCT number
- NCT02943239
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-08
- Primary completion
- 2019-04-30
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.